UnitedHealth Group (NYSE: UNH) insider transactions
In the twelve months to 10 November 2026, executives and directors of UnitedHealth Group reported 3 open-market sales of 2,469 shares ($944,910) and 0 open-market purchases, by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 October 2026 | Baker Charles D. | Director | Grant or award | +257 | — | 2,668 | Form 4 |
| 1 October 2026 | Flynn Timothy Patrick | Director | Grant or award | +262 | — | 11,205 | Form 4 |
| 1 October 2026 | Garcia Paul R | Director | Grant or award | +155 | — | 4,077 | Form 4 |
| 1 October 2026 | Garcia Paul R | Director | Grant or award | +103 | — | 4,180 | Form 4 |
| 1 October 2026 | Gil Kristen | Director | Grant or award | +240 | — | 2,867 | Form 4 |
| 1 October 2026 | Gottlieb Scott | Director | Grant or award | +257 | — | 921 | Form 4 |
| 1 October 2026 | McNabb Frederick William Iii | Director | Grant or award | +291 | — | 15,810 | Form 4 |
| 1 October 2026 | Montgomery Rice Valerie MD | Director | Grant or award | +257 | — | 8,180 | Form 4 |
| 1 October 2026 | Noseworthy John H | Director | Grant or award | +240 | — | 7,902 | Form 4 |
| 22 September 2026 | McSweeney Erin | EVP & Chief People Officer | Grant or award | +53 | — | 15,654 | Form 4 |
| 22 September 2026 | Noel Timothy John | Chief Executive Officer, UHC | Grant or award | +84 | — | 17,735 | Form 4 |
| 22 September 2026 | DeVeydt Wayne S | Chief Financial Officer | Grant or award | +106 | — | 18,676 | Form 4 |
| 22 September 2026 | Conway Patrick Hugh | Chief Executive Officer, Optum | Grant or award | +91 | — | 15,419 | Form 4 |
| 22 September 2026 | Gil Kristen | Director | Grant or award | +10 | — | 2,627 | Form 4 |
| 22 September 2026 | Garcia Paul R | Director | Grant or award | +16 | — | 3,922 | Form 4 |
| 22 September 2026 | Montgomery Rice Valerie MD | Director | Grant or award | +47 | — | 7,923 | Form 4 |
| 22 September 2026 | Hemsley Stephen J | CEO, Uhg | Grant or award | +50 | — | 177,690 | Form 4 |
| 22 September 2026 | Zaetta Christopher R | EVP & Chief Legal Officer | Grant or award | +67 | — | 15,927 | Form 4 |
| 22 September 2026 | Gottlieb Scott | Director | Grant or award | +5 | — | 664 | Form 4 |
| 22 September 2026 | Noseworthy John H | Director | Grant or award | +46 | — | 7,662 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the UnitedHealth Group page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.